Report Detail
Global Fusion Transcript Assays Market Growth (Status and Outlook) 2022-2028
- RnM4472628 |
- 26 July, 2022 |
- Global |
- 89 Pages |
- LPI(LP Information) |
- Medical Devices & Consumables
As the global economy mends, the 2021 growth of Fusion Transcript Assays will have significant change from previous year. According to our (LP Information) latest study, the global Fusion Transcript Assays market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Fusion Transcript Assays market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Fusion Transcript Assays market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Fusion Transcript Assays market, reaching US$ million by the year 2028. As for the Europe Fusion Transcript Assays landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Fusion Transcript Assays players cover Thermo Fisher Scientific, Illumina, Inc., Merck Millipore, and Hologic Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Fusion Transcript Assays market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Fusion Transcript Kits
PCR Devices
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Cancer Research Center
Diagnostic Laboratory
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher Scientific
Illumina, Inc.
Merck Millipore
Hologic Inc.
Hologic Inc Bio-Rad Laboratories Inc.
Caris Life Sciences
SeraCare Life Sciences Inc.
QIAGEN
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Fusion Transcript Assays Market Size 2017-2028
- 2.1.2 Fusion Transcript Assays Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Fusion Transcript Assays Segment by Type
- 2.2.1 Fusion Transcript Kits
- 2.2.2 PCR Devices
- 2.3 Fusion Transcript Assays Market Size by Type
- 2.3.1 Fusion Transcript Assays Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Fusion Transcript Assays Market Size Market Share by Type (2017-2022)
- 2.4 Fusion Transcript Assays Segment by Application
- 2.4.1 Hospital
- 2.4.2 Cancer Research Center
- 2.4.3 Diagnostic Laboratory
- 2.4.4 Others
- 2.5 Fusion Transcript Assays Market Size by Application
- 2.5.1 Fusion Transcript Assays Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Fusion Transcript Assays Market Size Market Share by Application (2017-2022)
3 Fusion Transcript Assays Market Size by Player
- 3.1 Fusion Transcript Assays Market Size Market Share by Players
- 3.1.1 Global Fusion Transcript Assays Revenue by Players (2020-2022)
- 3.1.2 Global Fusion Transcript Assays Revenue Market Share by Players (2020-2022)
- 3.2 Global Fusion Transcript Assays Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Fusion Transcript Assays by Regions
- 4.1 Fusion Transcript Assays Market Size by Regions (2017-2022)
- 4.2 Americas Fusion Transcript Assays Market Size Growth (2017-2022)
- 4.3 APAC Fusion Transcript Assays Market Size Growth (2017-2022)
- 4.4 Europe Fusion Transcript Assays Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Fusion Transcript Assays Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Fusion Transcript Assays Market Size by Country (2017-2022)
- 5.2 Americas Fusion Transcript Assays Market Size by Type (2017-2022)
- 5.3 Americas Fusion Transcript Assays Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Fusion Transcript Assays Market Size by Region (2017-2022)
- 6.2 APAC Fusion Transcript Assays Market Size by Type (2017-2022)
- 6.3 APAC Fusion Transcript Assays Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Fusion Transcript Assays by Country (2017-2022)
- 7.2 Europe Fusion Transcript Assays Market Size by Type (2017-2022)
- 7.3 Europe Fusion Transcript Assays Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Fusion Transcript Assays by Region (2017-2022)
- 8.2 Middle East & Africa Fusion Transcript Assays Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Fusion Transcript Assays Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Fusion Transcript Assays Market Forecast
- 10.1 Global Fusion Transcript Assays Forecast by Regions (2023-2028)
- 10.1.1 Global Fusion Transcript Assays Forecast by Regions (2023-2028)
- 10.1.2 Americas Fusion Transcript Assays Forecast
- 10.1.3 APAC Fusion Transcript Assays Forecast
- 10.1.4 Europe Fusion Transcript Assays Forecast
- 10.1.5 Middle East & Africa Fusion Transcript Assays Forecast
- 10.2 Americas Fusion Transcript Assays Forecast by Country (2023-2028)
- 10.2.1 United States Fusion Transcript Assays Market Forecast
- 10.2.2 Canada Fusion Transcript Assays Market Forecast
- 10.2.3 Mexico Fusion Transcript Assays Market Forecast
- 10.2.4 Brazil Fusion Transcript Assays Market Forecast
- 10.3 APAC Fusion Transcript Assays Forecast by Region (2023-2028)
- 10.3.1 China Fusion Transcript Assays Market Forecast
- 10.3.2 Japan Fusion Transcript Assays Market Forecast
- 10.3.3 Korea Fusion Transcript Assays Market Forecast
- 10.3.4 Southeast Asia Fusion Transcript Assays Market Forecast
- 10.3.5 India Fusion Transcript Assays Market Forecast
- 10.3.6 Australia Fusion Transcript Assays Market Forecast
- 10.4 Europe Fusion Transcript Assays Forecast by Country (2023-2028)
- 10.4.1 Germany Fusion Transcript Assays Market Forecast
- 10.4.2 France Fusion Transcript Assays Market Forecast
- 10.4.3 UK Fusion Transcript Assays Market Forecast
- 10.4.4 Italy Fusion Transcript Assays Market Forecast
- 10.4.5 Russia Fusion Transcript Assays Market Forecast
- 10.5 Middle East & Africa Fusion Transcript Assays Forecast by Region (2023-2028)
- 10.5.1 Egypt Fusion Transcript Assays Market Forecast
- 10.5.2 South Africa Fusion Transcript Assays Market Forecast
- 10.5.3 Israel Fusion Transcript Assays Market Forecast
- 10.5.4 Turkey Fusion Transcript Assays Market Forecast
- 10.5.5 GCC Countries Fusion Transcript Assays Market Forecast
- 10.6 Global Fusion Transcript Assays Forecast by Type (2023-2028)
- 10.7 Global Fusion Transcript Assays Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Thermo Fisher Scientific
- 11.1.1 Thermo Fisher Scientific Company Information
- 11.1.2 Thermo Fisher Scientific Fusion Transcript Assays Product Offered
- 11.1.3 Thermo Fisher Scientific Fusion Transcript Assays Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Thermo Fisher Scientific Main Business Overview
- 11.1.5 Thermo Fisher Scientific Latest Developments
- 11.2 Illumina, Inc.
- 11.2.1 Illumina, Inc. Company Information
- 11.2.2 Illumina, Inc. Fusion Transcript Assays Product Offered
- 11.2.3 Illumina, Inc. Fusion Transcript Assays Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Illumina, Inc. Main Business Overview
- 11.2.5 Illumina, Inc. Latest Developments
- 11.3 Merck Millipore
- 11.3.1 Merck Millipore Company Information
- 11.3.2 Merck Millipore Fusion Transcript Assays Product Offered
- 11.3.3 Merck Millipore Fusion Transcript Assays Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Merck Millipore Main Business Overview
- 11.3.5 Merck Millipore Latest Developments
- 11.4 Hologic Inc.
- 11.4.1 Hologic Inc. Company Information
- 11.4.2 Hologic Inc. Fusion Transcript Assays Product Offered
- 11.4.3 Hologic Inc. Fusion Transcript Assays Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Hologic Inc. Main Business Overview
- 11.4.5 Hologic Inc. Latest Developments
- 11.5 Hologic Inc Bio-Rad Laboratories Inc.
- 11.5.1 Hologic Inc Bio-Rad Laboratories Inc. Company Information
- 11.5.2 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Product Offered
- 11.5.3 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Hologic Inc Bio-Rad Laboratories Inc. Main Business Overview
- 11.5.5 Hologic Inc Bio-Rad Laboratories Inc. Latest Developments
- 11.6 Caris Life Sciences
- 11.6.1 Caris Life Sciences Company Information
- 11.6.2 Caris Life Sciences Fusion Transcript Assays Product Offered
- 11.6.3 Caris Life Sciences Fusion Transcript Assays Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Caris Life Sciences Main Business Overview
- 11.6.5 Caris Life Sciences Latest Developments
- 11.7 SeraCare Life Sciences Inc.
- 11.7.1 SeraCare Life Sciences Inc. Company Information
- 11.7.2 SeraCare Life Sciences Inc. Fusion Transcript Assays Product Offered
- 11.7.3 SeraCare Life Sciences Inc. Fusion Transcript Assays Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 SeraCare Life Sciences Inc. Main Business Overview
- 11.7.5 SeraCare Life Sciences Inc. Latest Developments
- 11.8 QIAGEN
- 11.8.1 QIAGEN Company Information
- 11.8.2 QIAGEN Fusion Transcript Assays Product Offered
- 11.8.3 QIAGEN Fusion Transcript Assays Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 QIAGEN Main Business Overview
- 11.8.5 QIAGEN Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Fusion Transcript Assays. Industry analysis & Market Report on Fusion Transcript Assays is a syndicated market report, published as Global Fusion Transcript Assays Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Fusion Transcript Assays market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
